Skip to content
No results
  • Home
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • About Us
  • Contact Us
The Pharma Data
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Research

Novotech Earns Prestigious US Great Place to Work® Certification

  • The Pharma Data
  • October 16, 2024

Novotech, a full-service international clinical contract research organization (CRO), is proud to announce its recognition as a U.S. Great Place to Work® certified company. This prestigious certification underscores Novotech’s commitment…

Read MoreNovotech Earns Prestigious US Great Place to Work® Certification
  • Press Releases

bit.bio Secures Major Patent Victory for Revolutionary opti-ox™ Cell Programming Technology

  • The Pharma Data
  • October 16, 2024

bit.bio has successfully defended its European patent for the groundbreaking opti-ox™ technology, which facilitates the precise programming of pluripotent stem cells (PSCs), including induced pluripotent stem cells (iPSCs), into any…

Read Morebit.bio Secures Major Patent Victory for Revolutionary opti-ox™ Cell Programming Technology
  • Press Releases

Marinus Pharmaceuticals Expands Intellectual Property with New Patent for ZTALMY® Titration Methods

  • The Pharma Data
  • October 16, 2024

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative treatments for seizure disorders, announced the addition of a new patent to its intellectual property portfolio. The United States…

Read MoreMarinus Pharmaceuticals Expands Intellectual Property with New Patent for ZTALMY® Titration Methods
  • News

Anthem Blue Cross and Open Table Launch Initiative to Tackle Youth Substance Use Disorder

  • The Pharma Data
  • October 16, 2024

As part of a three-year, $30 million initiative focused on mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation has launched a new program in Shenandoah County,…

Read MoreAnthem Blue Cross and Open Table Launch Initiative to Tackle Youth Substance Use Disorder
  • Regulatory

UroGen Announces FDA Acceptance of New Drug Application for UGN-102

  • The Pharma Data
  • October 16, 2024

PDUFA Goal Date Set for June 13, 2025: UGN-102 Could Be First FDA-Approved Treatment for LG-IR-NMIBC UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company committed to developing innovative solutions for…

Read MoreUroGen Announces FDA Acceptance of New Drug Application for UGN-102
  • News

FDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer Treatment

  • The Pharma Data
  • October 16, 2024

FDA Approves Optune Lua® as First-of-its-Kind Treatment for Metastatic Non-Small Cell Lung Cancer Novocure (NASDAQ: NVCR) announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua®, a…

Read MoreFDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer Treatment
  • Business

Lenovo Launches First AI Avatar for Alzheimer’s and Dementia Care

  • The Pharma Data
  • October 16, 2024

At Lenovo Tech World, Lenovo™, in collaboration with Innovations in Dementia, launched “Alzheimer’s Intelligence,” a photorealistic 3D avatar powered by AI, designed to support individuals and families affected by dementia…

Read MoreLenovo Launches First AI Avatar for Alzheimer’s and Dementia Care
  • Regulatory

FDA Clears SPECTRALIS Flex Module, Enhancing Advanced Ophthalmic Imaging for Underserved Patients

  • The Pharma Data
  • October 15, 2024

Heidelberg Engineering, a leading provider of ophthalmic imaging and healthcare data solutions, has announced that the FDA has granted clearance for its SPECTRALIS® Flex Module. This advanced, multimodal imaging platform…

Read MoreFDA Clears SPECTRALIS Flex Module, Enhancing Advanced Ophthalmic Imaging for Underserved Patients
  • Regulatory

Bausch + Lomb Gains FDA Approval for enVista Envy Intraocular Lens Offering Full Range of Vision

  • The Pharma Data
  • October 15, 2024

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global leader in eye health, has announced that the U.S. Food and Drug Administration has approved the enVista® Envy™ intraocular lens (IOL). This…

Read MoreBausch + Lomb Gains FDA Approval for enVista Envy Intraocular Lens Offering Full Range of Vision
  • News

Supergut Expands Nationwide at Target Amid Sales Surge

  • The Pharma Data
  • October 15, 2024

Supergut, the first clinically validated nutrition brand for gut health, is now available at Target stores across the U.S. and online at Target.com. The brand’s exclusive Target lineup features its…

Read MoreSupergut Expands Nationwide at Target Amid Sales Surge
  • Business

MEDiC Life Sciences Partners with Hanmi on Cancer Biomarker Discovery, Secures Strategic Investment

  • The Pharma Data
  • October 15, 2024

MEDiC Life Sciences, a biotech startup based in Silicon Valley, has announced a new research collaboration with Hanmi Pharmaceutical, a prominent biopharmaceutical company in Korea. The partnership aims to identify…

Read MoreMEDiC Life Sciences Partners with Hanmi on Cancer Biomarker Discovery, Secures Strategic Investment
  • Regulatory

Biogen’s Felzartamab Gains FDA Breakthrough Therapy Designation for Kidney Transplant Rejection

  • The Pharma Data
  • October 14, 2024

Biogen Inc. (Nasdaq: BIIB) – Biogen announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to felzartamab, an investigational anti-CD38 monoclonal antibody. This…

Read MoreBiogen’s Felzartamab Gains FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
PrevNext

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Exthymic Secures Up to $25M ARPA-H Contract for Hospital-Based Cell Therapy ProductionOctober 6, 2026
  • GE HealthCare to Acquire SOFIE Biosciences to Expand U.S. PET Radiopharmaceutical SupplyOctober 6, 2026
  • Epicrispr Reports Positive Six-Month EPI-321 Data in FSHD PatientsOctober 6, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.